US FDA issues Drug Safety Communication regarding known side effects of HCQ & chloroquine, including serious, potentially life-threatening heart rhythm problems

Source :: PharmaBiz. April 27, 2020
Publication Year :: 2020
Abstract: The US Food and Drug Administration (FDA) issued a Drug Safety Communication regarding known side effects of hydroxychloroquine (HCQ) and chloroquine, including serious and potentially life-threatening heart rhythm problems, that [...]

Subjects :: United States. Food and Drug Administration -- Safety and security measures
Drug therapy
Prevention
Analysis
Complications and side effects
Safety and security measures
Arrhythmia -- Complications and side effects -- Drug therapy -- Prevention
Heart rate -- Safety and security measures -- Analysis
Drugs -- Complications and side effects
Hydroxychloroquine -- Complications and side effects
Drug approval -- Safety and security measures -- Analysis
Hospital patients
Medical personnel
Setting (Literature)
Labels
Clinical trials

Tools